US Stock MarketDetailed Quotes

VRPX Virpax Pharmaceuticals

Watchlist
  • 0.6990
  • +0.0848+13.81%
Close Nov 18 16:00 ET
5.65MMarket Cap-96P/E (TTM)

Virpax Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-68.59%-4.47M
24.71%-1.64M
-284.86%-7.73M
44.79%-9.85M
-92.14%-3.01M
51.79%-2.65M
53.91%-2.18M
66.78%-2.01M
-22.72%-17.85M
68.16%-1.57M
Net income from continuing operations
66.53%-2.01M
-10.84%-3.45M
-111.80%-3.22M
29.84%-15.19M
-52.71%-4.56M
21.56%-5.99M
47.10%-3.11M
70.40%-1.52M
-79.58%-21.65M
27.46%-2.99M
Change In working capital
-177.67%-2.45M
143.70%1.73M
-629.08%-4.58M
56.62%4.79M
21.72%1.56M
57.98%3.15M
-21.29%711.59K
43.85%-628.42K
190.00%3.06M
235.49%1.28M
-Change in prepaid assets
6.39%278.72K
51.62%544.4K
6.11%-777.44K
-90.67%191.53K
-83.36%398.56K
-2.31%261.97K
-40.90%359.06K
32.04%-828.07K
175.66%2.05M
239.84%2.39M
-Change in payables and accrued expense
-96.24%-223.81K
237.49%1.19M
-252.36%-304.18K
160.36%599.43K
105.18%161.3K
-106.61%-114.05K
18.90%352.53K
101.26%199.65K
-44.60%-993.1K
-506.09%-3.11M
-Change in other current liabilities
-183.33%-2.5M
--0
---3.5M
100.00%4M
-50.00%1M
--3M
--0
--0
--2M
--2M
Cash from discontinued investing activities
Operating cash flow
-68.59%-4.47M
24.71%-1.64M
-284.86%-7.73M
44.79%-9.85M
-92.14%-3.01M
51.79%-2.65M
53.91%-2.18M
66.78%-2.01M
-22.72%-17.85M
68.16%-1.57M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
2.62M
1.65M
453.95K
0
0
0
Net common stock issuance
--0
----
----
----
----
--0
----
----
----
----
Proceeds from stock option exercised by employees
--2.77M
----
----
----
----
--0
----
----
----
----
Net other financing activities
---151.3K
---601.8K
--453.95K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--2.62M
--1.65M
--453.95K
----
----
--0
--0
--0
----
----
Net cash flow
Beginning cash position
-87.36%1.87M
-89.01%1.87M
-51.87%9.14M
-48.44%19M
-40.90%12.15M
-43.20%14.8M
-44.84%16.99M
-48.44%19M
67,134.82%36.84M
-50.71%20.56M
Current changes in cash
30.08%-1.85M
100.21%4.6K
-262.25%-7.28M
44.79%-9.85M
-92.14%-3.01M
51.79%-2.65M
53.91%-2.18M
66.78%-2.01M
-148.51%-17.85M
67.83%-1.57M
End cash Position
-99.86%17.23K
-87.36%1.87M
-89.01%1.87M
-51.87%9.14M
-51.87%9.14M
-40.90%12.15M
-43.20%14.8M
-44.84%16.99M
-48.44%19M
-48.44%19M
Free cash flow
-68.59%-4.47M
24.71%-1.64M
-284.86%-7.73M
44.79%-9.85M
-92.14%-3.01M
51.79%-2.65M
53.91%-2.18M
66.78%-2.01M
-22.72%-17.85M
68.16%-1.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -68.59%-4.47M24.71%-1.64M-284.86%-7.73M44.79%-9.85M-92.14%-3.01M51.79%-2.65M53.91%-2.18M66.78%-2.01M-22.72%-17.85M68.16%-1.57M
Net income from continuing operations 66.53%-2.01M-10.84%-3.45M-111.80%-3.22M29.84%-15.19M-52.71%-4.56M21.56%-5.99M47.10%-3.11M70.40%-1.52M-79.58%-21.65M27.46%-2.99M
Change In working capital -177.67%-2.45M143.70%1.73M-629.08%-4.58M56.62%4.79M21.72%1.56M57.98%3.15M-21.29%711.59K43.85%-628.42K190.00%3.06M235.49%1.28M
-Change in prepaid assets 6.39%278.72K51.62%544.4K6.11%-777.44K-90.67%191.53K-83.36%398.56K-2.31%261.97K-40.90%359.06K32.04%-828.07K175.66%2.05M239.84%2.39M
-Change in payables and accrued expense -96.24%-223.81K237.49%1.19M-252.36%-304.18K160.36%599.43K105.18%161.3K-106.61%-114.05K18.90%352.53K101.26%199.65K-44.60%-993.1K-506.09%-3.11M
-Change in other current liabilities -183.33%-2.5M--0---3.5M100.00%4M-50.00%1M--3M--0--0--2M--2M
Cash from discontinued investing activities
Operating cash flow -68.59%-4.47M24.71%-1.64M-284.86%-7.73M44.79%-9.85M-92.14%-3.01M51.79%-2.65M53.91%-2.18M66.78%-2.01M-22.72%-17.85M68.16%-1.57M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 2.62M1.65M453.95K000
Net common stock issuance --0------------------0----------------
Proceeds from stock option exercised by employees --2.77M------------------0----------------
Net other financing activities ---151.3K---601.8K--453.95K----------------------------
Cash from discontinued financing activities
Financing cash flow --2.62M--1.65M--453.95K----------0--0--0--------
Net cash flow
Beginning cash position -87.36%1.87M-89.01%1.87M-51.87%9.14M-48.44%19M-40.90%12.15M-43.20%14.8M-44.84%16.99M-48.44%19M67,134.82%36.84M-50.71%20.56M
Current changes in cash 30.08%-1.85M100.21%4.6K-262.25%-7.28M44.79%-9.85M-92.14%-3.01M51.79%-2.65M53.91%-2.18M66.78%-2.01M-148.51%-17.85M67.83%-1.57M
End cash Position -99.86%17.23K-87.36%1.87M-89.01%1.87M-51.87%9.14M-51.87%9.14M-40.90%12.15M-43.20%14.8M-44.84%16.99M-48.44%19M-48.44%19M
Free cash flow -68.59%-4.47M24.71%-1.64M-284.86%-7.73M44.79%-9.85M-92.14%-3.01M51.79%-2.65M53.91%-2.18M66.78%-2.01M-22.72%-17.85M68.16%-1.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data